Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)
Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)
批准号:
8017939
负责人:
THOMAS L VAUGHAN
金额:
$198.35万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-21 至 2012-08-31
关键词:
ApoptosisBarrett EsophagusBiologicalBlood specimenCancer EtiologyCandidate Disease GeneChronicComplexDNADNA DamageDNA RepairDataDevelopmentDiseaseEnvironmental Risk FactorEpidemicEpidemiologic StudiesEpitheliumEsophagealEsophageal AdenocarcinomaEtiologyFamilyFemaleFundingGastroesophageal reflux diseaseGenderGenesGeneticGenetic Predisposition to DiseaseGenetic VariationGenomeGenomicsGenotypeGoalsGonadal Steroid HormonesHumanIncidenceIndividualInflammationInflammatoryInsulin ResistanceInterviewKnowledgeLightMalignant NeoplasmsMediatingMeta-AnalysisMetabolicMethodsModelingNeoplastic ProcessesObesityOverweightOxidative StressParticipantPathogenesisPathway interactionsPatternPersonsPhasePlayPopulation ControlPrecancerous ConditionsPredispositionPrevalencePreventionProcessRefluxResearchResearch PersonnelResourcesRiskRisk FactorsRoleSamplingScreening procedureSeveritiesSourceStimulation of Cell ProliferationSymptomsSyndromeTechnologyTelomere MaintenanceTelomere ShorteningTwin Multiple BirthVariantabdominal pressurecancer riskcigarette smokingcofactorcostdesigngenetic risk factorgenome wide association studyhigh riskmalemodel developmentmodifiable riskpopulation basedpublic health relevance
中文摘要
描述(申请人提供):食管腺癌(EA),一种迅速致命的疾病,在过去的30年里,在美国的发病率比任何其他癌症增长得都快-超过500%。胃食道反流和肥胖已被发现是EA及其主要前体Barrett‘s食道(BE)发生的关键可改变的危险因素。然而,尽管反流似乎对肿瘤过程至关重要,但只有大约10%-15%的长期存在反流症状的人在有生之年出现反流症状;在那些有反流症状的人中,大多数人没有进展到电针。同样,肥胖增加EA风险的机制尚不清楚。因此,一定还有其他辅助因素调节与反流相关的对食道上皮的慢性炎症效应,以及超重的局部和全身后果,这在很大程度上决定了风险。这些辅因子中的许多很可能是由基因介导的,虽然家庭、双胞胎和候选基因研究支持这一概念,但还没有基因被确定为起因果作用。在这里,我们提出了一项大规模的全基因组关联研究,该研究利用了Barrett‘s和食管腺癌联合会(Beacon)的研究人员在18项流行病学研究中收集的大量数据,这些研究代表了世界上设计良好、主要基于人群的这些疾病研究的绝大多数。我们研究的总体目标是评估遗传易感性对EA和BE风险的影响。主要目的是确定与BE和EA风险最相关的标签SNP。在次要目标中,我们将根据这些疾病的关键环境和宿主风险因素,包括性别、肥胖和吸烟,评估最显著的关联的程度。我们建议在三年内采取一种单一阶段的方法,涉及7,500名参与者,他们都曾就主要的环境和宿主风险因素接受过访谈,并捐献了血液样本。Illumina Infinium人类610-四芯片将用于对大约1500例EA、3000例BE和3000例人群对照进行基因分型。已经确定了其他样本和数据来源,以提供复制研究(资金将另行申请)。Beacon的资源,加上基因组技术和分析方法的最新进展,为a)研究遗传和环境因素对这些重要疾病病因学的影响提供了独特且具有成本效益的机会,b)帮助确定其发病机制中的关键生物途径,以及c)帮助针对高危人群,以便最有效地指导筛查、预防和监测工作。公共卫生相关性:食管腺癌是一种迅速致命的疾病,其发病率在过去30年中增加了6倍以上。通过使用18项流行病学研究的汇集数据和DNA进行大规模全基因组关联研究,我们建议评估遗传易感性对这种癌症及其主要癌前疾病Barrett‘s食道的风险的影响,并确定这些疾病的易感因素根据关键环境和宿主风险因素的不同程度。这些结果将有助于确定这种癌症的病因学中重要的生物途径,并帮助针对高危人群,以便最有效地指导筛查、预防和监测工作。
英文摘要
DESCRIPTION (provided by applicant): The incidence of esophageal adenocarcinoma (EA), a rapidly fatal disease, has increased faster than any other cancer in the US over the last three decades - over 500 percent. Gastroesophageal reflux and obesity have been found to be key modifiable risk factors for the development of EA and its main precursor, Barrett's esophagus (BE). However, while reflux appears to be crucial to the neoplastic process, only about 10 - 15 percent of individuals with long-standing reflux symptoms develop BE in their lifetimes; among those who do, most do not progress to EA. Similarly, the mechanisms by which obesity increases risk of EA are not known. Thus, there must be other cofactors modulating the reflux-related chronic inflammatory effects on the esophageal epithelium and the local and systemic consequences of being overweight, that largely determine risk. Many of these cofactors are likely to be genetically mediated, and while family, twin and candidate gene studies support this notion, no genes have been established yet as playing a causal role. Here, we propose a large-scale genome-wide association study which takes advantage of the extensive data collected by investigators in the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) in 18 epidemiologic studies, representing the vast majority of the well-designed largely population-based studies of these diseases in the world. The overall goal of our research is to evaluate the influence of genetic susceptibility on risk of EA and BE. The primary aim is to identify tagSNPs most strongly associated with risk of BE and EA. In secondary aims we will evaluate the extent to which the most significant associations vary according to key environmental and host risk factors for these conditions, including gender, obesity and cigarette smoking. We propose a single phase approach over three years involving 7,500 participants, all of whom have been previously interviewed regarding major environmental and host risk factors and have donated blood specimens. The Illumina Infinium Human 610-Quad Chip will be used to genotype approximately 1,500 cases of EA, 3,000 cases of BE and 3,000 population controls. Additional sources of samples and data have been identified to provide replication studies (funding to be requested separately.) The resources of BEACON, together with recent advances in genomic technology and analytic methods, present a unique and cost-effective opportunity to a) study the influence of genetic and environmental factors in the etiology of these important diseases, b) aid in the identification of key biological pathways in their pathogenesis, and c) help target persons at highest risk so that screening, prevention and surveillance efforts can be directed most effectively. PUBLIC HEALTH RELEVANCE: The incidence of esophageal adenocarcinoma, a rapidly fatal disease, has increased more than six-fold over the past 30 years. By conducting a large-scale genome-wide association study using pooled data and DNA from 18 epidemiologic studies, we propose to evaluate the influence of genetic susceptibility on risk of this cancer and its main precancerous condition, Barrett's esophagus, and determine the extent to which susceptibility factors vary according to key environmental and host risk factors for these conditions. These results will aid in the identification of biological pathways important in the etiology of this cancer, and help target persons at highest risk so that screening, prevention and surveillance efforts can be directed most effectively.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
METABOLITE BIOIMARKERS IN THE DEVELOPMENT OF ESOPHAGEAL ADENOCARCINOMA
-
批准号:8571375
-
项目类别:
-
资助金额:$24.76万
-
财政年份:2013
-
负责人:THOMAS L VAUGHAN
-
依托单位:
METABOLITE BIOIMARKERS IN THE DEVELOPMENT OF ESOPHAGEAL ADENOCARCINOMA
-
批准号:8726352
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2013
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)
-
批准号:8145246
-
项目类别:
-
资助金额:$123.08万
-
财政年份:2009
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)
-
批准号:7730733
-
项目类别:
-
资助金额:$344.89万
-
财政年份:2009
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Established Investigator Award in Cancer Prevention and Control
-
批准号:7629722
-
项目类别:
-
资助金额:$15.36万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Established Investigator Award in Cancer Prevention and Control
-
批准号:8098685
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROL
-
批准号:8702923
-
项目类别:
-
资助金额:$15.12万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Established Investigator Award in Cancer Prevention and Control
-
批准号:7923553
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
EPIDEMIOLOGY OF PROGRESSION IN BARRETT'S ESOPHAGUS
-
批准号:7305720
-
项目类别:
-
资助金额:$26.16万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Established Investigator Award in Cancer Prevention and Control
-
批准号:7878656
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROL
-
批准号:8522164
-
项目类别:
-
资助金额:$15.12万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROL
-
批准号:8384552
-
项目类别:
-
资助金额:$15.12万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Established Investigator Award in Cancer Prevention and Control
-
批准号:7321857
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Established Investigator Award in Cancer Prevention and Control
-
批准号:7473907
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROL
-
批准号:9129605
-
项目类别:
-
资助金额:$15.12万
-
财政年份:2007
-
负责人:THOMAS L VAUGHAN
-
依托单位:
CORE--Environmental Carcinogenesis
-
批准号:6876446
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2005
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Clinical Risk Assessment and Prediction
-
批准号:8668334
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2002
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Insulin-like Growth Factors & Esophageal Adenocarcinoma
-
批准号:6667105
-
项目类别:
-
资助金额:$8.65万
-
财政年份:2002
-
负责人:THOMAS L VAUGHAN
-
依托单位:
Insulin-like Growth Factors & Esophageal Adenocarcinoma
-
批准号:6589236
-
项目类别:
-
资助金额:$8.65万
-
财政年份:2002
-
负责人:THOMAS L VAUGHAN
-
依托单位:
EPIDEMIOLOGY OF BARRETTS ESOPHAGUS
-
批准号:6172847
-
项目类别:
-
资助金额:$54.27万
-
财政年份:1997
-
负责人:THOMAS L VAUGHAN
-
依托单位:
海外基金